Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Datto

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|July 14, 2009
NDRG4 is required for cell cycle progression and survival in glioblastoma cellsStephen H Schilling, Anita B Hjelmeland, Daniel R Radiloff, et al.
Infection Control and Hospital Epidemiology|August 4, 2020
Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence areaSarah S Lewis, Becky A Smith, Ibukunoluwa C Akinboyo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcomeWilliam T Barry, Dawn N Kernagis, Holly K Dressman, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United StatesAnivarya Kumar, Jennifer R Owen, Nicholette T Sloat, et al.
The Oncologist|August 13, 2022
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor BoardMichelle F Green, Catherine H Watson, Sarah Tait, et al.
Journal of Gastrointestinal Oncology|November 16, 2023
Identification of an optimal mutant allele frequency to detect activating <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomasBennett A Caughey, Kumiko Umemoto, Michelle F Green, et al.
The Journal of Biological Chemistry|March 4, 2008
Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscleAnne A Wooldridge, Christopher N Fortner, Beata Lontay, et al.
MMWR. Morbidity and Mortality Weekly Report|November 19, 2020
Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020Thomas N Denny, Laura Andrews, Mattia Bonsignori, et al.
Nature Communications|May 20, 2022
Automated next-generation profiling of genomic alterations in human cancersLaurel A Keefer, James R White, Derrick E Wood, et al.
Biorxiv : the Preprint Server for Biology|July 21, 2022
Mapping SARS-CoV-2 antigenic relationships and serological responsesSamuel H Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|July 14, 2009
NDRG4 is required for cell cycle progression and survival in glioblastoma cellsStephen H Schilling, Anita B Hjelmeland, Daniel R Radiloff, et al.
Infection Control and Hospital Epidemiology|August 4, 2020
Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence areaSarah S Lewis, Becky A Smith, Ibukunoluwa C Akinboyo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcomeWilliam T Barry, Dawn N Kernagis, Holly K Dressman, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United StatesAnivarya Kumar, Jennifer R Owen, Nicholette T Sloat, et al.
The Oncologist|August 13, 2022
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor BoardMichelle F Green, Catherine H Watson, Sarah Tait, et al.
Journal of Gastrointestinal Oncology|November 16, 2023
Identification of an optimal mutant allele frequency to detect activating <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomasBennett A Caughey, Kumiko Umemoto, Michelle F Green, et al.
The Journal of Biological Chemistry|March 4, 2008
Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscleAnne A Wooldridge, Christopher N Fortner, Beata Lontay, et al.
MMWR. Morbidity and Mortality Weekly Report|November 19, 2020
Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020Thomas N Denny, Laura Andrews, Mattia Bonsignori, et al.
Nature Communications|May 20, 2022
Automated next-generation profiling of genomic alterations in human cancersLaurel A Keefer, James R White, Derrick E Wood, et al.
Biorxiv : the Preprint Server for Biology|July 21, 2022
Mapping SARS-CoV-2 antigenic relationships and serological responsesSamuel H Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Pageof 4